HEMATOLOGY

Supportive Care and Survivorship Strategies in Management of Squamous Cell Carcinoma of the Head and Neck

Sep 16, 2017 by in HEMATOLOGY Comments Off on Supportive Care and Survivorship Strategies in Management of Squamous Cell Carcinoma of the Head and Neck

Supportive care and survivorship strategies in the management of head and neck squamous cell carcinoma (HNSCC) revolve around continued collaborative efforts aimed at early identification and intervention for locoregional disease…

read more

Salivary Gland Malignancies

Sep 16, 2017 by in HEMATOLOGY Comments Off on Salivary Gland Malignancies

Salivary gland malignant tumors represent a diverse group of neoplasms. Their low incidence makes research studies challenging, with most therapeutic recommendations based on case reviews, single-arm trials, or small randomized…

read more

Thyroid Gland Malignancies

Sep 16, 2017 by in HEMATOLOGY Comments Off on Thyroid Gland Malignancies

Surgery remains the most important effective treatment for differentiated (DTC) and medullary thyroid cancer (MTC). Radioactive iodine (RAI) is another important treatment but is reserved only for DTC whose disease…

read more

Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies

Sep 16, 2017 by in HEMATOLOGY Comments Off on Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies

Radiotherapy is the primary treatment of nasopharyngeal carcinoma and combination chemotherapy can enhance treatment outcomes for locoregionally advanced disease. The Intergroup 0099 study using concurrent-adjuvant cisplatin-based chemoradiotherapy was the first…

read more

Sequential and Concurrent Chemoradiation

Sep 16, 2017 by in HEMATOLOGY Comments Off on Sequential and Concurrent Chemoradiation

Most patients diagnosed with head and neck cancer have locally advanced disease. Sequential and concurrent chemoradiation are standard, nonsurgical, curative-intent treatment options. Controversy remains regarding the superiority of one approach…

read more

Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient

Sep 16, 2017 by in HEMATOLOGY Comments Off on Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient

Human papillomavirus (HPV) is the cause of a distinct subset of oropharyngeal cancer rising in incidence in the United States and other developed countries. This increased incidence, combined with the…

read more
Get Clinical Tree app for offline access